Shaping the future of European epilepsy research: Final meeting report from EPICLUSTER

[1]  Anthony Maher,et al.  Applying Patient and Public Involvement in preclinical research: A co‐created scoping review , 2022, Health expectations : an international journal of public participation in health care and health policy.

[2]  F. Ginhoux,et al.  Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling , 2022, Nature neuroscience.

[3]  S. Schorge,et al.  Gene Therapy for Neurological Disease: State of the Art and Opportunities for Next-generation Approaches , 2022, Neuroscience.

[4]  M. Brodie,et al.  Meeting report: EpiXchange II brings together European epilepsy research projects to discuss latest advances , 2021, Epilepsy Research.

[5]  M. Lalu,et al.  Patient engagement in preclinical laboratory research: A scoping review , 2021, EBioMedicine.

[6]  N. Delanty,et al.  Democratizing epilepsy care: Utility and usability of an electronic patient portal , 2021, Epilepsy & Behavior.

[7]  A. Pitkänen,et al.  Identification of clinically relevant biomarkers of epileptogenesis — a strategic roadmap , 2021, Nature Reviews Neurology.

[8]  Derek Corrigan,et al.  LoVE in a time of CoVID: Clinician and patient experience using telemedicine for chronic epilepsy management , 2020, Epilepsy & Behavior.

[9]  Madeline A. Lancaster,et al.  Brain organoids for the study of human neurobiology at the interface of in vitro and in vivo , 2020, Nature Neuroscience.

[10]  Brian Litt,et al.  Multimodal in vivo recording using transparent graphene microelectrodes illuminates spatiotemporal seizure dynamics at the microscale , 2020, bioRxiv.

[11]  Josemir W Sander,et al.  Psychiatric Comorbidities in People With Epilepsy. , 2020, Neurology. Clinical practice.

[12]  L. Concha,et al.  Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study , 2020, Science Advances.

[13]  P. Kwan,et al.  30 years of second-generation antiseizure medications: impact and future perspectives , 2020, The Lancet Neurology.

[14]  H. Mefford,et al.  Epilepsy Benchmarks Area III: Improved Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects , 2020, Epilepsy currents.

[15]  D. Binder,et al.  Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression , 2020, Epilepsy currents.

[16]  E. Marsh,et al.  Epilepsy Benchmarks Area I: Understanding the Causes of the Epilepsies and Epilepsy-Related Neurologic, Psychiatric, and Somatic Conditions , 2020, Epilepsy currents.

[17]  E. Felton,et al.  Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across the Life Span , 2020, Epilepsy currents.

[18]  D. Kullmann,et al.  Novel therapies for epilepsy in the pipeline , 2019, Epilepsy & Behavior.

[19]  S. Sisodiya,et al.  Advancing research toward faster diagnosis, better treatment, and end of stigma in epilepsy , 2019, Epilepsia.

[20]  Anthony G. Wilson,et al.  Facilitating public and patient involvement in basic and preclinical health research , 2019, PloS one.

[21]  Fares Alahdab,et al.  Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[22]  L. Forsythe,et al.  Evaluating patient and public involvement in research , 2018, British Medical Journal.

[23]  James G. Scott,et al.  Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016 , 2018, Schizophrenia bulletin.

[24]  D. Kullmann,et al.  In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy , 2020, Brain : a journal of neurology.

[25]  Eyal Oren,et al.  Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, The Lancet. Neurology.

[26]  Philippe Ryvlin,et al.  Biallelic variants in LARS2 and KARS cause deafness and (ovario)leukodystrophy , 2017, Neurology.

[27]  B. Jespersen,et al.  Optogenetic control of human neurons in organotypic brain cultures , 2016, Scientific Reports.

[28]  Orrin Devinsky,et al.  Sudden, unexpected death in epilepsy. , 2011, The New England journal of medicine.